About us
The Department of Preclinical Imaging and Radiopharmacy is one of five Departments within the Radiology at the University Hospital Tübingen (UKT).
Herein, the Werner Siemens Imaging Center funded by the Swiss Werner Siemens Foundation has evolved from a small laboratory into a leading international imaging science center over the last 10 years. The interdisciplinary nature of our team is mirrored in the variety of research areas covered by the Werner Siemens Imaging Center.
We invite you to screen our web pages to learn about our research and the fascinating options that preclinical and molecular imaging offers.
Latest press releases and Links
Latest News
Prof. Bernd Pichler honored with ESMI Award 2025
Congratulations to Bernd Pichler, Director of Werner Siemens Imaging Center, for receiving the 2025 ESMI Award!
Prof. Pichler was award the highest honor given by the European Society for Molecular Imaging (ESMI).
The award was presented to him during the 20th Annual Meeting of ESMI in Bilbao by the chair of the award selection committee Kevin Brindle.
Prof. Pichler receives the ESMI Award for his pioneering work in the development of preclinical and clinical PET/MRI devices, for his work on innovative imaging probes for use in oncology, immunology and neurology, and for his dedication, passion and tireless advocacy for cross-field collaboration.
New Professorship on Radiochemistry and Imaging Probe Development: Welcome Prof. Dr. Anna Junker
We are happy to welcome Prof. Dr. Anna Junker as new Professor in our department. Starting from January 2024 she will lead the Radiochemistry and Imaging Probe Development group located within the WSIC. As part of the iFIT Cluster of Excellence she will focus on the development of novel ligands and inhibitors for various oncologically relevant G-protein coupled receptors, ion channels and enzymes as well as further development of these ligands and inhibitors into imaging probes.
WSIC receives funding in the European IMAGIO research consortium
The European research consortium IMAGIO "Imaging and Advanced Guidance for workflow optimization in Interventional Oncology" is funded with 24 million euros by the Innovative Health Initiative (IHI). The consortium consists of up to 30 partner organizations, ranging from hospitals and research institutions to companies from the healthcare sector. The three Tübingen institutions involved in IMAGIO are the Department of Preclinical Imaging and Radiopharmacy (Prof. Dr. Bernd Pichler), the Department of Medical Oncology and Pneumology (Prof. Dr. Lars Zender) and the Department of Nuclear Medicine and Clinical Molecular Imaging (Prof. Dr. Christian la Fougère).
Click here for fruther information. Read more about the IMAGIO consotium here
